Contact this trialFirst, we need to learn more about you.
TIN816 for Acute Kidney Injury
Recruiting0 awardsPhase 2
Vancouver, British Columbia
This trial is studying the effects of a drug called TIN816 on patients who have a condition called sepsis-associated acute kidney injury. The researchers want to understand how different doses of the drug affect
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service